General MedicationsORALGeneric

THEO-DUR

THEOPHYLLINE

Standard Dose

300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview THEO-DUR is listed in Drugs@FDA under application 085328 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 2002-01-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview THEO-DUR is listed in Drugs@FDA under application 085328 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 2002-01-10 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.